Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tosan Darou is a prominent Iranian pharmaceutical and biotechnology company specializing in the development and manufacture of high-tech medicinal products. The company is most notably recognized for its flagship product, Masport, a botulinum toxin type A used for both therapeutic neurological conditions and aesthetic applications. Tosan Darou operates advanced manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards, enabling the production of complex biologics. Beyond its toxin portfolio, the company provides a range of specialized generic pharmaceuticals to the domestic and regional Middle Eastern markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tosan darou.